Today

Agents

Chat

Arena

Discover

More

App

Legend Biotech announces annual general meeting - LEGN News | Rallies

Legend Biotech announces annual general meeting

LEGN•2026-08-18

Annual general meeting details

Legend Biotech schedules its annual general meeting in Bridgewater, New Jersey on Sept. 24, 2026.
Shareholders will receive the audited consolidated financial statements for the year ended Dec. 31, 2025.
Vote set on ratifying Ernst & Young LLP as independent auditor for the year ending Dec. 31, 2026.
Ballot includes re-election of four Class III directors for new three-year terms.
Proposal seeks to expand the 2020 Restricted Shares Plan reserve by 19,100,000 ordinary shares.

Related News

United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $4.79 million

UTHR•2026-08-18

Toll Brothers FY26 Q3 net income drops 24.2% to $280.1 million; home sales revenues fall to $2.65 billion

TOL•2026-08-18

AXIL Brands Q4 revenue rises 49% on big-box retail orders

Sources

S

Legend Biotech announces annual general meeting

Sec

AXIL

•

2026-08-18

Elanco GC, Corporate Secretary Shiv O’Neill buys 3,998 common shares for $94,278.84

ELAN•2026-08-18

CirTran FY26 Q2 net loss narrows 81.8% to $95,517; net sales rise 595.6% to $1.17 million

CIRX•2026-08-18